InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ABEONA THERAPEUTICS INC.

ABEO Clue Score64
United States Fiscal year ends December CIK 0000318306
$4.94 -0.40% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.94 +437.07% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.9Operating income−23.9Net income−21.9Fiscal year 2017Revenue0.8 −5.8%Operating income−27.8Net income−27.3Fiscal year 2018Revenue3.0 +258.2%Operating income−58.2Net income−56.7Fiscal year 2019Operating income−77.1Net income−76.3Fiscal year 2020Revenue10.0Operating income−81.4Net income−84.2Fiscal year 2021Revenue3.0 −70.0%Operating income−89.8Net income−84.9Fiscal year 2022Revenue1.4 −52.9%Operating income−50.9Net income−39.7EPS, diluted−5.53Fiscal year 2023Revenue3.5 +147.5%Operating income−47.1Net income−54.2EPS, diluted−2.53Fiscal year 2024Operating income−64.2Net income−63.7EPS, diluted−1.55Fiscal year 2025Revenue5.8Operating income−89.4Net income71.2EPS, diluted1.01
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.9 0.8 3.0 n/a 10.0 3.0 1.4 3.5 n/a 5.8
Growth −5.8% +258.2% −70.0% −52.9% +147.5%
Operating income −23.9 −27.8 −58.2 −77.1 −81.4 −89.8 −50.9 −47.1 −64.2 −89.4
Net income −21.9 −27.3 −56.7 −76.3 −84.2 −84.9 −39.7 −54.2 −63.7 71.2
Growth
EPS, diluted n/a n/a n/a n/a n/a n/a −5.53 −2.53 −1.55 1.01

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−2,686.3%Net margin−2,460.4%Free cash flow margin−1,522.3%Fiscal year 2017Operating margin−3,325.7%Net margin−3,263.9%Free cash flow margin−2,809.4%Fiscal year 2018Operating margin−1,940.2%Net margin−1,890.3%Free cash flow margin−1,612.9%Fiscal year 2019Fiscal year 2020Operating margin−814.2%Net margin−842.3%Free cash flow margin−363.6%Fiscal year 2021Operating margin−2,994.5%Net margin−2,831.2%Free cash flow margin−2,327.2%Fiscal year 2022Operating margin−3,600.8%Net margin−2,807.4%Free cash flow margin−3,084.4%Fiscal year 2023Operating margin−1,346.7%Net margin−1,548.2%Free cash flow margin−1,066.9%Fiscal year 2024Fiscal year 2025Operating margin−1,536.9%Net margin1,223.1%Free cash flow margin−1,448.5%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −2,686.3% −3,325.7% −1,940.2% n/a −814.2% −2,994.5% −3,600.8% −1,346.7% n/a −1,536.9%
Net margin −2,460.4% −3,263.9% −1,890.3% n/a −842.3% −2,831.2% −2,807.4% −1,548.2% n/a 1,223.1%
Free cash flow margin −1,522.3% −2,809.4% −1,612.9% n/a −363.6% −2,327.2% −3,084.4% −1,066.9% n/a −1,448.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−13.0Capital expenditure−0.5Free cash flow−13.5Fiscal year 2017Operating cash flow−22.7Capital expenditure−0.9Free cash flow−23.5Fiscal year 2018Operating cash flow−39.1Capital expenditure−9.2Free cash flow−48.4Fiscal year 2019Operating cash flow−62.8Capital expenditure−6.3Free cash flow−69.1Fiscal year 2020Operating cash flow−35.0Capital expenditure−1.3Free cash flow−36.4Fiscal year 2021Operating cash flow−65.7Capital expenditure−4.2Free cash flow−69.8Fiscal year 2022Operating cash flow−43.5Capital expenditure−0.1Free cash flow−43.6Fiscal year 2023Operating cash flow−37.0Capital expenditure−0.3Free cash flow−37.3Fiscal year 2024Operating cash flow−56.0Capital expenditure−2.4Free cash flow−58.5Fiscal year 2025Operating cash flow−76.3Capital expenditure−8.0Free cash flow−84.3
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −13.0 −22.7 −39.1 −62.8 −35.0 −65.7 −43.5 −37.0 −56.0 −76.3
Capital expenditure −0.5 −0.9 −9.2 −6.3 −1.3 −4.2 −0.1 −0.3 −2.4 −8.0
Free cash flow −13.5 −23.5 −48.4 −69.1 −36.4 −69.8 −43.6 −37.3 −58.5 −84.3
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash69.1Shareholders’ equity99.1Fiscal year 2017Cash137.8Shareholders’ equity170.1Fiscal year 2018Cash18.8Shareholders’ equity134.0Fiscal year 2019Cash129.3Shareholders’ equity178.4Fiscal year 2020Cash12.6Shareholders’ equity102.6Fiscal year 2021Cash32.9Shareholders’ equity42.4Fiscal year 2022Cash14.2Shareholders’ equity26.8Fiscal year 2023Cash14.5Shareholders’ equity14.8Fiscal year 2024Cash23.4Total debt19.0Net cash (debt)4.4Shareholders’ equity44.0Debt to equity0.43Fiscal year 2025Cash78.4Total debt20.0Net cash (debt)58.4Shareholders’ equity159.2Debt to equity0.13
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 69.1 137.8 18.8 129.3 12.6 32.9 14.2 14.5 23.4 78.4
Total debt n/a n/a n/a n/a n/a n/a n/a n/a 19.0 20.0
Net cash (debt) n/a n/a n/a n/a n/a n/a n/a n/a 4.4 58.4
Shareholders’ equity 99.1 170.1 134.0 178.4 102.6 42.4 26.8 14.8 44.0 159.2
Debt to equity n/a n/a n/a n/a n/a n/a n/a n/a 0.43 0.13

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
0.9 0.8 3.0 n/a 10.0 3.0 1.4 3.5 n/a 5.8
Growth −5.8% +258.2% −70.0% −52.9% +147.5%
n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.5
10.7 17.0 38.7 48.6 30.1 38.7 29.0 31.1 34.4 26.8
13.3 10.9 20.1 20.7 23.8 21.6 17.3 19.0 29.9 65.0
−23.9 −27.8 −58.2 −77.1 −81.4 −89.8 −50.9 −47.1 −64.2 −89.4
Growth
n/a n/a n/a n/a n/a n/a n/a n/a −63.7 71.3
0.0 0.0 0.0 n/a n/a n/a n/a n/a n/a 0.1
−21.9 −27.3 −56.7 −76.3 −84.2 −84.9 −39.7 −54.2 −63.7 71.2
Growth
Per share
n/a n/a n/a n/a n/a −21.57 −5.53 −2.53 −1.55 1.34
n/a n/a n/a n/a n/a n/a −5.53 −2.53 −1.55 1.01
Growth
34.2 n/a n/a n/a n/a 3.9 7.9 21.4 41.0 53.0
n/a n/a n/a n/a n/a n/a 7.9 21.4 41.0 66.1
Growth +172.0% +92.0% +61.1%

† The diluted share count jumps at 2023 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 14.2% a year over five years.
  • Operating margin is up 403.3 points on five years ago, at -1,536.9%.
  • A net loss in 9 of 10 years on file.